kras mutation and glutathion glynac Treatment of KRAS-Mutated Pancreatic Cancer: New Hope for the Patients? Pancreatic Cancer: Advances and Challenges
Pancreatic Cancer: Advances and Challenges PMC Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism: Cell Metabolic reprogramming in KRAS mutant cancers: Proven targetable vulnerabilities and potential therapeutic strategies ScienceDirect Mutant KRas Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions ScienceDirect Targeting mutated GTPase KRAS in tumor therapies ScienceDirect
Pay in 4 interest-free payments of $5.52 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




